1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Cui Y and Jia J: Update on epidemiology of
hepatitis B and C in China. J Gastroenterol Hepatol. 28 Suppl
1:S7–S10. 2013. View Article : Google Scholar
|
3
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127 5 Suppl 1:S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Block TM, Mehta AS, Fimmel CJ and Jordan
R: Molecular viral oncology of hepatocellular carcinoma. Oncogene.
22:5093–5107. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
An G, Ng AY, Meka CS, Luo G, Bright SP,
Cazares L, Wright GL Jr and Veltri RW: Cloning and characterization
of UROC28, a novel gene overexpressed in prostate, breast, and
bladder cancers. Cancer Res. 60:7014–7020. 2000.PubMed/NCBI
|
8
|
Loizidou MA, Cariolou MA, Neuhausen SL,
Newbold RF, Bashiardes E, Marcou Y, Michael T, Daniel M, Kakouri E,
Papadopoulos P, et al: Genetic variation in genes interacting with
BRCA1/2 and risk of breast cancer in the Cypriot population. Breast
Cancer Res Treat. 121:147–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Samusik N, Krukovskaya L, Meln I, Shilov E
and Kozlov AP: PBOV1 is a human de novo gene with tumor-specific
expression that is associated with a positive clinical outcome of
cancer. PLoS One. 8:e561622013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Doak SH, Jenkins SA, Hurle RA, Varma M,
Hawizy A, Kynaston HG and Parry JM: Bone morphogenic factor gene
dosage abnormalities in prostatic intraepithelial neoplasia and
prostate cancer. Cancer Genet Cytogenet. 176:161–165. 2007.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Pan T, Wu R, Liu B, Wen H, Tu Z, Guo J,
Yang J and Shen G: PBOV1 promotes prostate cancer proliferation by
promoting G1/S transition. Onco Targets Ther. 9:787–795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Krukovskaia LL, Samusik ND, Shilov ES,
Polev DE and Kozlov AP: Tumor-specific expression of PBOV1, a new
gene in evolution. Vopr Onkol. 56:327–332. 2010.(In Russian).
PubMed/NCBI
|
13
|
Kamagata C, Tsuji N, Kondoh K, Sasaki M,
Kobayashi D, Yagihashi A and Watanabe N: Enhanced expression of the
UROC28 gene in human breast cancer: Relationship to ERBB2 gene
expression. Anticancer Res. 22:4087–4091. 2002.PubMed/NCBI
|
14
|
Wang L, Niu CH, Wu S, Wu HM, Ouyang F, He
M and He SY: PBOV1 correlates with progression of ovarian cancer
and inhibits proliferation of ovarian cancer cells. Oncol Rep.
35:488–496. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC cancer staging manual. 7th ed.
Springer; New York: pp. 191–200. 2010
|
16
|
Yamashita Y, Taketomi A, Shirabe K,
Aishima S, Tsuijita E, Morita K, Kayashima H and Maehara Y:
Outcomes of hepatic resection for huge hepatocellular carcinoma
(≥10 cm in diameter). J Surg Oncol. 104:292–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hahn WC, Dessain SK, Brooks MW, King JE,
Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA: Enumeration
of the simian virus 40 early region elements necessary for human
cell transformation. Mol Cell Biol. 22:2111–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Song L, Wang L, Li Y, Xiong H, Wu J, Li J
and Li M: Sam68 up-regulation correlates with, and its
down-regulation inhibits, proliferation and tumourigenicity of
breast cancer cells. J Pathol. 222:227–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Ma W, Yu Q, Jiang J, Du X, Huang L, Zhao L
and Zhou QI: miR-517a is an independent prognostic marker and
contributes to cell migration and invasion in human colorectal
cancer. Oncol Lett. 11:2583–2589. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang G, Huang J, Zhu H, Ju S, Wang H and
Wang X: Overexpression of GRO-β is associated with an unfavorable
outcome in colorectal cancer. Oncol Lett. 11:2391–2397. 2016.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Tang B, Tang F, Wang Z, Qi G, Liang X, Li
B, Yuan S, Liu J, Yu S and He S: Overexpression of CTNND1 in
hepatocellular carcinoma promotes carcinous characters through
activation of Wnt/β-catenin signaling. J Exp Clin Cancer Res.
35:822016. View Article : Google Scholar : PubMed/NCBI
|